Benjamin P Linas

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Hepatitis C screening trends in a large integrated health system
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, Mass Department of Epidemiology, Boston University School of Public Health, Boston, Mass Electronic address
    Am J Med 127:398-405. 2014
  2. pmc Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
    Clin Infect Dis 55:279-90. 2012
  3. pmc Priorities for screening and treatment of latent tuberculosis infection in the United States
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Boston Medical Center, Section of Infectious Disease, Evans Biomedical Research Center, 650 Albany St Rm 647, Boston, MA 02118, USA
    Am J Respir Crit Care Med 184:590-601. 2011
  4. pmc Improving outcomes in state AIDS drug assistance programs
    Benjamin P Linas
    Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 51:513-21. 2009
  5. ncbi request reprint The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 9:e97317. 2014
  6. pmc When to start antiretroviral therapy in resource-limited settings
    Rochelle P Walensky
    Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
    Ann Intern Med 151:157-66. 2009
  7. pmc Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC
    Rochelle P Walensky
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 51:392-400. 2010
  8. ncbi request reprint The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Benjamin P Linas
    aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:365-76. 2014
  9. ncbi request reprint Optimizing resource allocation in United States AIDS drug assistance programs
    Benjamin P Linas
    Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 43:1357-64. 2006
  10. pmc Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients
    Sabrina A Assoumou
    Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA
    Sex Transm Dis 40:298-303. 2013

Detail Information

Publications12

  1. ncbi request reprint Hepatitis C screening trends in a large integrated health system
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, Mass Department of Epidemiology, Boston University School of Public Health, Boston, Mass Electronic address
    Am J Med 127:398-405. 2014
    ..As new hepatitis C virus (HCV) therapies emerge, only 1%-12% of individuals are screened in the US for HCV infection. Presently, HCV screening trends are unknown...
  2. pmc Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
    Clin Infect Dis 55:279-90. 2012
    ..We used a Monte Carlo computer simulation to estimate the effectiveness and cost-effectiveness of screening for acute hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected men who have sex with men...
  3. pmc Priorities for screening and treatment of latent tuberculosis infection in the United States
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Boston Medical Center, Section of Infectious Disease, Evans Biomedical Research Center, 650 Albany St Rm 647, Boston, MA 02118, USA
    Am J Respir Crit Care Med 184:590-601. 2011
    ..To improve the effectiveness of tuberculosis (TB) control programs in the United States by identifying cost-effective priorities for screening for latent tuberculosis infection (LTBI)...
  4. pmc Improving outcomes in state AIDS drug assistance programs
    Benjamin P Linas
    Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 51:513-21. 2009
    ..State AIDS Drug Assistance Programs (ADAPs) provide antiretroviral medications to patients with no access to medications. Resource constraints limit the ability of many ADAPs to meet demand for services...
  5. ncbi request reprint The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 9:e97317. 2014
    ..We used simulation modeling to estimate the impact of loss to follow-up on HCV treatment outcomes and to identify intervention strategies likely to provide good value for the resources invested in them...
  6. pmc When to start antiretroviral therapy in resource-limited settings
    Rochelle P Walensky
    Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
    Ann Intern Med 151:157-66. 2009
    ..The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years...
  7. pmc Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC
    Rochelle P Walensky
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 51:392-400. 2010
    ..We forecast outcomes of this approach if implemented in Washington DC...
  8. ncbi request reprint The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Benjamin P Linas
    aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:365-76. 2014
    ..To evaluate the effectiveness and cost-effectiveness of strategies to treat hepatitis C virus (HCV) in HIV/HCV coinfected patients in the United States...
  9. ncbi request reprint Optimizing resource allocation in United States AIDS drug assistance programs
    Benjamin P Linas
    Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Clin Infect Dis 43:1357-64. 2006
    ..We hypothesized that CD4 cell count-based ADAP eligibility would improve ADAP outcomes, allowing them to serve more-diverse patient populations and to prioritize persons who are at greatest risk of HIV-related mortality...
  10. pmc Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients
    Sabrina A Assoumou
    Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA
    Sex Transm Dis 40:298-303. 2013
    ..Currently, there is no consensus on posttreatment surveillance of HIV-infected men who have sex with men (MSM) who have been treated for high-grade intraepithelial neoplasia (HGAIN), the likely precursor to anal cancer...
  11. pmc First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
    AIDS 25:479-92. 2011
    ..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine...
  12. pmc Assessing the impact of federal HIV prevention spending on HIV testing and awareness
    Benjamin P Linas
    Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA
    Am J Public Health 96:1038-43. 2006
    ..The United States allocates more than $900 million annually for the prevention of HIV infection. We assessed the impact of this funding on HIV testing and knowledge...